Heidi S. Harvie, MBA, MD, MSCE
Associate Professor of Obstetrics and Gynecology at the Pennsylvania Hospital
Senior Fellow, Leonard Davis Institute of Health Economics,
University of Pennsylvania, The Wharton School
, University of Pennsylvania
Director of Urogynecology at Pennsylvania Hospital, Pennsylvania Hospital
Chief, Urogynecology, University of Pennsylvania
Department: Obstetrics and Gynecology
Contact information
Pennsylvania Hospital
Urogynecology and Pelvic Reconstructive Surgery
Penn Medicine at Washington Square, 10th floor
Philadelphia, PA 19107
Urogynecology and Pelvic Reconstructive Surgery
Penn Medicine at Washington Square, 10th floor
Philadelphia, PA 19107
Education:
B.B.A. (Accounting/Management - magna cum laude)
University of Pennsylvania, The Wharton School, Philadelphia, PA, 1989.
M.D.
University of Pennsylvania School of Medicine, Philadelphia, PA, 2002.
M.B.A. (Business Admin in Health Care - with honors)
University of Pennsylvania, The Wharton School, Philadelphia, PA, 2002.
M.S.C.E.
University of Pennsylvania School of Medicine, Philadelphia, PA, 2009.
Permanent linkB.B.A. (Accounting/Management - magna cum laude)
University of Pennsylvania, The Wharton School, Philadelphia, PA, 1989.
M.D.
University of Pennsylvania School of Medicine, Philadelphia, PA, 2002.
M.B.A. (Business Admin in Health Care - with honors)
University of Pennsylvania, The Wharton School, Philadelphia, PA, 2002.
M.S.C.E.
University of Pennsylvania School of Medicine, Philadelphia, PA, 2009.
Selected Publications
Harvie HS, Chermansky C, Richter HE: Midurethral Sling vs OnabotulinumtoxinA for Urinary Incontinence-Reply. JAMA 334(16): 1488-1489, Oct 2025.Muñoz JM, Kim EK, Andy UU, Mumford SL, Harvie HS: Variation in Overactive Bladder Treatment Type by Social Determinants of Health. Urogynecology 31(10): 929-941, Oct 2025.
Walter JR, Richards EG, Johannesson L, Falcone T, Testa G, O'Neill KE, Harvie HS: Cost-effectiveness Analysis of Uterus Transplantation versus Gestational Carrier for Treatment of Absolute Uterine Factor Infertility. Fertil Steril 124(1): 121-133, Jul 2025.
Reaves S, Levin, PJ, Harvie HS, Andy UU: Factors Affecting Follow-up for Specialty Postpartum Care after Obstetric Anal Sphincter Injury at a Single U.S. Institution. Int Urogynecol J 36(7): 1457-1463, Jul 2025.
Harvie HS, Menefee SA, Richter HE, Sung VW, Chermansky CJ, Rahn DD, Amundsen CL, Arya LA, Rhodes E, Mazloomdoost D, Thomas S, National Institute of Child Health and Human Development Pelvic Floor Disorders Network: Midurethral Sling vs OnabotulinumtoxinA in Females With Urinary Incontinence: The MUSA Randomized Clinical Trial. JAMA 333(21): 1887-1896, Jun 2025.
Arya LA, Agrawal S, Ikpeama N, Harvie HS, Feldman RH, Dutcher L: Implementing a Digital Platform for Recurrent Urinary Tract Infections. Urogynecology 31(3): 183-193, Mar 2025.
Lukacz ES, Menefee SA, Carper B, Collins S, McMillian K, Florian-Rodriguez M, Rardin C, Weidner AC, Harvie HS, Alexander B, Mazloomdoost D, NICHD Pelvic Floor Disorders Network: Design of Transurethral Bulking Agent Injection Versus Single-Incision SlingTrial. Urogynecology 2025.
Gilmore E, McAllister A, Russell LB, Montoya M, Koelper NC, Schreiber CA, Harvie HS: Validity and Responsiveness of EQ-5D-5L in the Abortion Care Setting. Am J Obstet Gynecol. 2025.
CX Hong , M O'Leary, W Horner, PC Schmidt, HS Harvie, NS Kamdar, DM Morgan: Decreasing Utilization of Vaginal Hysterectomy in the United States: An Analysis by Candidacy for Vaginal Approach. Int Urogynecol J 35(10): 1983-1991, Oct 2024.
Gleason E, Andriani L, Tubridy EA, Uwawuike D, Gunter S, Koelper NC, Harvie HS, Ko EM: Cost of care associated with utilization of telehealth in clinical trials. Gynecol Oncol Rep 56: 101523, Oct 2024.